2012-10-31 06:41:34 - Actelion Ltd - SWOT, Strategy and Corporate Finance Report - a new company profile report on companiesandmarkets.com

Actelion Ltd - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company´s structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360˚ view of the company.

Features:

- Detailed information on Actelion Ltd required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Actelion Ltd in the form of a SWOT analysis
- An in-depth view of the business model of Actelion Ltd including a breakdown and examination of key business segments
- Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios for Actelion Ltd
- Intelligence on Actelion Ltdnv´s mergers

 

 

and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Actelion Ltd, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Highlights:

Actelion is a biopharmaceutical company focused on the discovery, development and commercialization of synthetic, small-molecule drugs to address high unmet medical needs. The company has subsidiaries in more than 25 countries including the US, Canada, Brazil, Australia, Japan and Switzerland, which provide distribution, sales and marketing services. It has operations in Americas, Europe and Asia-Pacific. The company is headquartered in Allschwil, Switzerland and employed 2,441 people as of December 31, 2010. The company recorded revenues of CHF1,929 million ($1,851.4 million*) during the financial year (FY) ended December 2010, an increase of 8.8% over 2009. The operating profit of the company was CHF457.3 million ($438.9 million*) during FY2010, an increase of 34.7% over 2009. The net profit was CHF390.6 million ($374.9 million*) in FY2010, an increase of 25.5% over 2009. *Calculated using the constant conversion rate of CHF1 = $0.9598 for the financial year ended December 31, 2010.
Reasons to Purchase:

- Gain understanding of Actelion Ltd and the factors that influence its strategies
- Track strategic initiatives of the company and latest corporate news and actions
- Assess Actelion Ltd as a prospective partner, vendor or supplier
- Support sales activities by understanding your customers´ businesses better
- Stay up to date on Actelion Ltd´s business structure, strategy and prospects

Click for report details: www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..

Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..

Browse all Healthcare and Medical Company Profile Reports www.companiesandmarkets.com/Market/Healthcare-and-Medical/Compan ..

Browse all Latest Company Profile Reports www.companiesandmarkets.com/Market/All/Company-Profile?aCode=f3f ..

About Us
Companiesandmarkets.com is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles, Companiesandmarkets.com’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.